Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon M Steichen

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The EMBO Journal|August 9, 2018
One-step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock-in miceYing-Cing Lin, Simone Pecetta, Jon M Steichen, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primatesMaureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
NPJ Vaccines|August 12, 2023
Optimization of an alum-anchored clinical HIV vaccine candidateKristen A Rodrigues, Christopher A Cottrell, Jon M Steichen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2025
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primatesMaureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
Nature Communications|August 1, 2025
Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3Gyunghee Jo, Seiya Yamayoshi, Krystal M Ma, et al.
Science (New York, N.Y.)|December 22, 2018
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centersTalar Tokatlian, Benjamin J Read, Christopher A Jones, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2025
Augmented humoral responses to HIV Env trimers delivered as transmembrane immunogens by self-replicating RNAParisa Yousefpour, Amrit Raj Ghosh, Himanshi Chawla, et al.
Science Immunology|October 17, 2025
Simultaneous induction of multiple classes of broadly neutralizing antibody precursors by combination germline-targeting immunization in nonhuman primatesHenry J Sutton, Krystal M Ma, Jon M Steichen, et al.
Nature Communications|November 23, 2017
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 bindingDaniel W Kulp, Jon M Steichen, Matthias Pauthner, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The EMBO Journal|August 9, 2018
One-step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock-in miceYing-Cing Lin, Simone Pecetta, Jon M Steichen, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primatesMaureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
NPJ Vaccines|August 12, 2023
Optimization of an alum-anchored clinical HIV vaccine candidateKristen A Rodrigues, Christopher A Cottrell, Jon M Steichen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2025
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primatesMaureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
Nature Communications|August 1, 2025
Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3Gyunghee Jo, Seiya Yamayoshi, Krystal M Ma, et al.
Science (New York, N.Y.)|December 22, 2018
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centersTalar Tokatlian, Benjamin J Read, Christopher A Jones, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2025
Augmented humoral responses to HIV Env trimers delivered as transmembrane immunogens by self-replicating RNAParisa Yousefpour, Amrit Raj Ghosh, Himanshi Chawla, et al.
Science Immunology|October 17, 2025
Simultaneous induction of multiple classes of broadly neutralizing antibody precursors by combination germline-targeting immunization in nonhuman primatesHenry J Sutton, Krystal M Ma, Jon M Steichen, et al.
Nature Communications|November 23, 2017
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 bindingDaniel W Kulp, Jon M Steichen, Matthias Pauthner, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.
Pageof 5